Dallah shareholders to vote on 622,450 shares buyback on Oct. 19

Logo of Dallah Healthcare Co.

Dallah Healthcare Co. shareholders will hold, on Oct. 19, an extraordinary general assembly meeting (EGM) to vote on the board of directors’ recommendation to repurchase up to 622,450 shares. The shares are intended to be held as treasury shares, with the aim of allocating them for the company’s employee stock incentive program (ESIP).

In a statement on Tadawul, the company stated that the repurchase will be self-financed and that the board of directors will have the authority to complete the transaction no later than 18 months after the EGM decision.

For more news on listed companies

Dallah will retain the repurchased shares for up to seven years from the EGM date. Following this time frame, the company will adhere to the policies and regulations set forth in the relevant laws and regulations.

The EGM will also vote on the board of directors’ recommendation to change the purpose of holding 377,550 treasury shares, which were originally intended for use in future swap transactions for acquiring shares or stakes in another company, or for asset purchases. The new purpose will be to allocate them under the ESIP.

Additionally, the assembly will decide on electing new board members for the upcoming four-year next term ending on Oct. 20, 2029.

Shareholders will also vote on establishing the ESIP (long-term incentive plan), authorizing the board of directors to set its terms and oversee its implementation, as well as competition standards, and authorizing the board to distribute interim dividends on a semi-annual or quarterly basis for 2026.